Wednesday, January 23, 2013

• Yahoo, Dell Swell Netherlands’ $13 Trillion Tax Havenat Bloomberg (Wed, Jan 23)

Tuesday, January 22, 2013

• Impax Laboratories Falls as FDA Rejects Parkinson’s Drugat Bloomberg (Tue, Jan 22)
• One Biotech Pony, Lots of Tricksat Motley Fool (Tue, Jan 22)
• Glaxo Plaintiff Lawyers Settle Dispute Over $143 Millionat Bloomberg (Tue, Jan 22)
• Trials Of Niacin And Atrial Fibrillation Device Will Headline American College Of Cardiology Programat Forbes (Tue, Jan 22)
• 3 Pharma Stocks That Could Be Good For Youat Forbes (Tue, Jan 22)
• J&J Beats on EPS but Guidance LagsZacks (Tue, Jan 22)
• Claman's Davos Notebook: Who to Expect at Davosat Fox Business (Tue, Jan 22)
• J&J: Investors Sick Over Low 2013 Profit Forecast, Despite Rebound In Q4at Forbes (Tue, Jan 22)
• Special interests gather for own inaugural partiesAP (Tue, Jan 22)

Monday, January 21, 2013

• Billionaire Horse Breeder’s Polio Shot to Undercut Glaxoat Bloomberg (Mon, Jan 21)
• A Look At 5 Healthcare Giants' Pre-Q4 2012 Earnings Releasesat Seeking Alpha (Mon, Jan 21)
• Which Drug Stocks have the Strongest Earnings Trends?at Wall St. Cheat Sheet (Mon, Jan 21)
• Age-Related Macular Degeneration: A Promising Investment Opportunityat Seeking Alpha (Mon, Jan 21)
• Impax Fails to Win Approval for Parkinson’s Drugat Bloomberg (Mon, Jan 21)

Saturday, January 19, 2013

• The Amazing P53 Raceat Seeking Alpha (Sat, Jan 19)
• Glaxo Accord Said to Spur Lawyer Fight Over Feesat Bloomberg (Sat, Jan 19)
• J&J Said to Offer Implant Pact That May Reach $2 Billionat Bloomberg (Sat, Jan 19)

Friday, January 18, 2013

• Merck: Recent Pullback Creates A Buying Opportunityat Seeking Alpha (Fri, Jan 18)
• This Biotech's on the NuPathe to Successat Motley Fool (Fri, Jan 18)
• Dell Leveraged Buyout May Hinge on Cash Hoard Outside U.S.at Bloomberg (Fri, Jan 18)
• Merck & Co Inc Stock Buy Recommendation Reiterated (MRK)at TheStreet (Fri, Jan 18)
• Deja Vu: A 10% Jump for That?at Motley Fool (Fri, Jan 18)
• What's Ahead for Ariad?at Motley Fool (Fri, Jan 18)

Thursday, January 17, 2013

• Big Pharma's Special Sauceat Motley Fool (Thu, Jan 17)

Add MRK News to My Yahoo!